Диссертация (1140202), страница 16
Текст из файла (страница 16)
Клиническиевариантыпоражениясердцаприсистемныхваскулитах//Терапевтический архив. – 2008. – Т. 80. – № 9. – C. 79-80.35. Тареев Е.М. Нефриты / Е.М. Тареев. – М.: Медгиз, 1958. – С. 452-464.36. Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ.Pulmonary-renal syndrome in a newborn with placental transmission ofANCAs.
Am J Kidney Dis 2005; 45:758–61.37. Silva F, Specks U, Sethi S, Irazabal MV, Fervenza FC. Successfulpregnancy and delivery of a healthy newborn despite transplacentaltransfer of antimyeloperoxidase antibodies from a mother withmicroscopic polyangiitis. Am J Kidney Dis 2009; 54: 542–5.10538. Sada KE, Yamamura M, Harigai M et al. Classification and characteristicsof Japanese patients with antineutrophil cytoplasmic antibody-associatedvasculitis in a nationwide, prospective, inception cohort study. ArthritisRes Ther 2014; 16: R10139.
Furuta S, Chaudhry AN, Hamano Y et al. Comparison of phenotype andoutcome in microscopic polyangiitis between Europe and Japan. JRheumatol 2014; 41: 325–33340. Huang H, Wang YX, Jiang CG et al. A retrospective study of microscopicpolyangiitis patients presenting with pulmonary fibrosis in China. BMCPulm Med 2014; 14: 841. Xiao H, Diraghi DJ, Powers JP et al.: C5a receptor (CD88) blockadeprotects against MPO-ANCA GN. J Am Soc Nephrol 2014; 25: 225-31.42. Jayne DRW, Bruchfekd AN, Harper L et al.. Randomized Trial of C5aReceptor Inhibitor Avacopan in ANCA-Associated Vasculitis. J Am SocNephrol 2017; 28: 2756-6743. Lyons PA, Rayner TF, Trivedi S, Holle JU,Watts RA, Jayne DR, et al.Genetically distinct subsets within ANCA-associated vasculitis.
N Engl JMed 2012;367:214e23.44. Н.М. Буланов, С.В. Моисеев, П.И. Новиков, Е.И. Кузнецова, А.Д.Мешков, Е.И. Макаров, Л.В. Козловская, Н.А. Мухин Поражениепочек при различных вариантах АНЦА-ассоциированного васкулита.2016. – Том 25, №5.
– С.23.2945. KallenbergCGM, Stegeman CA, Abdulahad WH, Heeringa P.Pathogenesis of ANCAassociated vasculitis: new possibilities forintervention. Am J Kidney Dis 2013; 62: 1176 e87.46. ЕгороваЕ.Т.,ТомилинаБыстропрогрессирующийН.А.,БирюковагломерулонефритЛ.С.при[идр.].АНЦА-ассоциированных васкулитах: течение, эффективность лечения,прогноз // Нефрология и диализ.
– 2007. – Т. 9. – № 3. – C. 228-239.10647. Т.В. Бекетова Микросокопический полиангиит, ассоциированный сантинейтрофильнымицитоплазматическимиантителами:особенности клинического течения \\ Терапевтический архив. – 2015.– Т. 87 №5. – С. 33-46.48. Тареев Е.М., Насонова В.А. Поражение легких при системныхваскулитах. // Советская медицина. – 1957. - №8.
– с. 3-12.49. Wilke L, Prince-Fiocco M, Fiocco GP. Microscopic polyangiitis: a largesingle-center series. J Clin Rheumatol 2014;20:179–82.50. Novikov P, Smitienko I, Bulanov N, Zykova A, Moiseev S. Testing forantineutrophil cytoplasmic antibodies (ANCAs) in patients with systemicvasculitides and other diseases //Ann Rheum Dis. 2016 Dec 23.51. Quintana LF, Peréz NS, De Sousa E, Rodas LM, Griffiths MH, Solé M,Jayne D. ANCA serotype and histopathological classification for theprediction of renal outcome in ANCA-associated glomerulonephritis.Nephrol Dial Transplant. 2014;29(9):1764-9. doi: 10. 1093/ndt/ gfu08452.
Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH,Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC; EuropeanVasculitis Study Group (EUVAS). Renal histology in ANCA-associatedvasculitis: differences between diagnostic and serologic subgroups.Kidney Int. 2002;61(1):80-9. doi: 10.1046/j.1523-1755.2002. 00089.x53. Rowaiye O. O., Kusztal M., Klinger M. The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis // Clinical KidneyJournal.
‒ 2015. ‒ T. 8, № 3. ‒ C. 343-350.54. Егорова Е.Т., Суханов А.В., Столяревич Е.С. [и др.]. Гемодиализ-зависимаяпочечнаянедостаточностьвдебютенефропатий:нозологическая структура, клинико-морфологиеские корреляции,прогноз // Вестник трансплантологии и искусственных органов. –2007. – № 5. – C. 20-26.10755.
Yamagata M, Ikeda K, Tsushima K, et al. Prevalence and responsivenessto treatment of lung abnormalities on chest computed tomography inpatients with microscopic polyangiitis: a multicenter, longitudinal,retrospective study of one hundred fifty consecutive hospital-basedJapanese patients. Arthritis Rheumatol 2016; 68:713–723.56. Hirayama K, Kobayashi M, Usui J, et al. Pulmonary involvements ofantineutrophil cytoplasmic autoantibody-associated renal vasculitis inJapan.
Nephrol Dial Transplant 2015; 30 (Suppl 1):i83–i93.57. Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, et al.Microscopic polyangiitis with alveolar hemorrhage. A study of 29 casesand review of the literature. Groupe d'Etudes et de Recherche sur lesMaladies “Orphelines” Pulmonaires (GERM“O”P). Medicine (Baltimore)2000;79:222–33.58. Collins CE, Quismorio Jr FP. Pulmonary involvement in microscopicpolyangiitis.
Curr Opin Pulm Med 2005;11:447–5159. Franks TJ, Koss MN. Pulmonary capillaritis. Curr Opin Pulm Med2000;6:430–5.60. Е.А. Коган, Б.М. Корнев, Е.Н. Попова [и др.]; под ред. Н.А. Мухина.Интерстициальные болезни легких: практическое руководство / М.:Литера, 2007. — 432 с.61. Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, et al. Diffuse alveolarhemorrhage secondary to antineutrophil cytoplasmic antibody-associatedvasculitis. Predictors of respiratory failure and clinical outcomes. ArthritisRheumatol. 2016;68:1467–76.62. Kostianovsky A, Hauser T, Pagnoux C et al.
Alveolar haemorrhage inANCA-associated vasculitides: 80 patients’ features and prognosticfactors. Clin Exp Rheumatol 2012; 30: S77–S8263. Gallagher H, Kwan JT, Jayne DR. Pulmonary renal syndrome: a 4-year,single-center experience. Am J Kidney Dis 2002; 39: 42–4710864. Kagiyama N,Takayanagi N, Kanauchi T, et al. Antineutrophilcytoplasmic antibody-positive conversion and microscopic polyangiitisdevelopment in patients with idiopathic pulmonary fibrosis.
BMJ OpenResp Res. 2015;2:e000058. A relevant article which describes that somepatients with IPF can evolve to MPA, and the influence of GC treatment(or not) in possibly evolving to that endpoint.65. Watts RA, Scott DG, Jayne DR et al. Renal vasculitis in Japan and the UK—are there differences in epidemiology and clinical phenotype? NephrolDial Transplant 2008; 23: 3928–393166. Hervier B, Pagnoux C, Agard C et al. Pulmonary fibrosis associated withANCA-positive vasculitides. Retrospective study of 12 cases and reviewof the literature. Ann Rheum Dis 2009; 68: 404–40767. Ono N, Niiro H, Ueda A, et al.
Characteristics of MPO-ANCA-positivegranulomatosis with polyangiitis: a retrospective multicenter study inJapan.Rheumatol Int 2015; 35:555–559.68. Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, etal. Prevalence and outcome of pulmonary fibrosis in microscopicpolyangiitis. Eur Respir J 2010; 36:116–21.69. Comarmond C., Crestani B., Tazi A. et al. Pulmonary Fibrosis inAntineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.Medicine (Baltimore). 2014 Nov; 93(24): 340-349.70.
Birnbaum J, Danoff S, Askin FB, Stone JH. Microscopic polyangiitispresenting as a “pulmonary-muscle” syndrome: is subclinical alveolarhemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum2007;56:2065–71.71. АвдеевС.Н. Идиопатический легочный фиброз: современнаяконцепцияиподходыкдиагностике.пульмонология. – 2004. - №4. – с.
16-23.109//Практическая72. ПоповаЕ.Н., Пономарев А.Б., Попова И.А., БолевичС.А.Клиническое значение медиаторов эндотелиальной дисфункции впрогрессировании интерстициальных болезней легких. Вестниксовременной клинической медицины 2010; 4: 32-37.73. Gomez-Puerta JA, Espinosa G,Morlà R, Cid MC, Cervera R. Interstitiallung disease as a presenting manifestation of microscopic polyangiitissuccessfully treated with mycophenolate mofetil.
Clin Exp Rheumatol2009;27:166–7.74. Kluger N, Pagnoux C, Guillevin L, Francès C. French Vasculitis StudyGroup. Comparison of cutaneous manifestations in systemic polyarteritisnodosa and microscopic polyangiitis. Br J Dermatol 2008;159:615–20.75. Kawakami T, Soma Y, Saito C, Ogawa H, Nagahuchi Y, Okazaki T, et al.Cutaneous manifestations in patients with microscopic polyangiitis: twocase reports and a minireview. Acta Derm Venereol 2006;86:144–7.76. Pagnoux C,Mahr A, Cohen P, Guillevin L. Presentation and outcome ofgastrointestinal involvement in systemic necrotizing vasculitides: analysisof 62 patients with polyarteritis nodosa, microscopic polyangiitis,Wegener granulomatosis, Churg–Strauss syndrome, or rheumatoidarthritis-associated vasculitis. Medicine (Baltimore) 2005;84:115–28.77.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
